Table 3.
Proportion of respondents that would report hypothetical cases of ADRs in line with the National Pharmacovigilance Centre reporting criteria
| Reactiona | Yes | No | Don't know |
| Palpitation with Coartem® (Yes)b | 58 (59.2%) | 20 (20.4%) | 20 (20.4%) |
| Skin rashes with roxithromycin (Yes)b | 54 (55.1%) | 26 (26.5%) | 18 (18.4%) |
| Jaundice with frusemide (Yes)b | 53 (54.1%) | 21 (21.4%) | 24 (24.5%) |
| Thrombocytopenia with heparin (Yes)b | 39 (39.8%) | 36 (36.7%) | 23 (23.5%) |
| Hiccup with enalapril (No)b | 36 (36.7%) | 29 (29.6%) | 33 (33.7%) |
| Gastrointestinal bleed with diclofenac (Yes)b | 35 (35.7%) | 41 (41.8%) | 22 (22.4%) |
| Headache with isordil dinitrate (No)b | 33 (33.7%) | 41 (41.8%) | 22 (22.4%) |
a Number of doctors responding (n = 98), b Response refer to standard NPC reporting in Nigeria.